Prices Drop at Last for Transformative Cancer Drug
It’s not often that drugs can completely transform the trajectory of a disease — but for chronic myeloid leukemia (CML), that is what tyrosine kinase inhibitors (TKIs) have done. They have changed an invariably lethal disease into a manageable chronic condition.
